WINREVAIR 45 mg, powder and solvent for solution for injection bottle, 1 ml + 1 needle
Active ingredients: Sotatercept
Commercialized according to BDPMDispensing in France: Prescription only
Powder and solvent for solution for injectionbottle, 1 ml + 1 needlesous-cutanée
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- WINREVAIR 45 mg, poudre et solvant pour solution injectable
- Pharmaceutical form
- poudre et solvant pour solution injectable
- Route of administration
- sous-cutanée
- Presentation description
- 1 flacon en verre de 45 mg + 1 seringue préremplie en verre de 1 mL + 1 dispositif de transfert + 1 seringue doseuse + 1 aiguille + 4 lingettes alcoolisées
- Marketing authorisation holder
- MERCK SHARP & DOHME (PAYS-BAS)
- Reimbursement according to BDPM
- 100 %
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 27 Feb 2025
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Requires special monitoring during treatment
- Prescribed by a hospital doctor
- Prescribed by specialists only
- Enhanced ANSM monitoring
- Yes
BDPM identifiers
CIS
61615894CIP73029853CIP133400930298534Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| SOTATERCEPTpoudre | 45 mg · un flacon | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.